| Product Code: ETC7537217 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India autoimmune disease treatment market import shipment demonstrated a consistent upward momentum with a CAGR of 4.3% from 2020 to 2024. The growth rate between 2023 and 2024 accelerated to 5.6%, indicating an expanding market trend.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Autoimmune Disease Treatment Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Autoimmune Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 India Autoimmune Disease Treatment Market - Industry Life Cycle |
3.4 India Autoimmune Disease Treatment Market - Porter's Five Forces |
3.5 India Autoimmune Disease Treatment Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Autoimmune Disease Treatment Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 India Autoimmune Disease Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 India Autoimmune Disease Treatment Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.9 India Autoimmune Disease Treatment Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.10 India Autoimmune Disease Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.11 India Autoimmune Disease Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 India Autoimmune Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in India |
4.2.2 Growing awareness about autoimmune diseases and available treatment options |
4.2.3 Advancements in healthcare infrastructure and technologies in India |
4.3 Market Restraints |
4.3.1 High cost of autoimmune disease treatments |
4.3.2 Lack of skilled healthcare professionals specialized in autoimmune diseases in India |
4.3.3 Limited access to advanced treatment options in rural areas |
5 India Autoimmune Disease Treatment Market Trends |
6 India Autoimmune Disease Treatment Market, By Types |
6.1 India Autoimmune Disease Treatment Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Autoimmune Disease Treatment Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 India Autoimmune Disease Treatment Market Revenues & Volume, By B Cell Inhibitors, 2021- 2031F |
6.1.4 India Autoimmune Disease Treatment Market Revenues & Volume, By T Cell Inhibitors, 2021- 2031F |
6.1.5 India Autoimmune Disease Treatment Market Revenues & Volume, By Tumor Necrosis Factor Inhibitors, 2021- 2031F |
6.1.6 India Autoimmune Disease Treatment Market Revenues & Volume, By Interleukin Inhibitors, 2021- 2031F |
6.1.7 India Autoimmune Disease Treatment Market Revenues & Volume, By Immunosuppressants,, 2021- 2031F |
6.1.8 India Autoimmune Disease Treatment Market Revenues & Volume, By Beta Interferons, 2021- 2031F |
6.1.9 India Autoimmune Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 India Autoimmune Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Autoimmune Disease Treatment Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Autoimmune Disease Treatment Market Revenues & Volume, By Graves Disease, 2021- 2031F |
6.2.3 India Autoimmune Disease Treatment Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.2.4 India Autoimmune Disease Treatment Market Revenues & Volume, By Hashimotos Thyroiditis, 2021- 2031F |
6.2.5 India Autoimmune Disease Treatment Market Revenues & Volume, By Vitiligo, 2021- 2031F |
6.2.6 India Autoimmune Disease Treatment Market Revenues & Volume, By Type 1 Diabetes, 2021- 2031F |
6.2.7 India Autoimmune Disease Treatment Market Revenues & Volume, By Pernicious Anemia, 2021- 2031F |
6.3 India Autoimmune Disease Treatment Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Autoimmune Disease Treatment Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.3.3 India Autoimmune Disease Treatment Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.3.4 India Autoimmune Disease Treatment Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.3.5 India Autoimmune Disease Treatment Market Revenues & Volume, By Pharmacies, 2021- 2031F |
6.3.6 India Autoimmune Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Autoimmune Disease Treatment Market, By Disease |
6.4.1 Overview and Analysis |
6.4.2 India Autoimmune Disease Treatment Market Revenues & Volume, By Crohn's Disease, 2021- 2031F |
6.4.3 India Autoimmune Disease Treatment Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.4.4 India Autoimmune Disease Treatment Market Revenues & Volume, By Inflammatory Bowel Disease, 2021- 2031F |
6.4.5 India Autoimmune Disease Treatment Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.4.6 India Autoimmune Disease Treatment Market Revenues & Volume, By Systemic Lupus Erythematosus, 2021- 2031F |
6.4.7 India Autoimmune Disease Treatment Market Revenues & Volume, By Psoriasis, 2021- 2031F |
6.5 India Autoimmune Disease Treatment Market, By Mechanism of Action |
6.5.1 Overview and Analysis |
6.5.2 India Autoimmune Disease Treatment Market Revenues & Volume, By TNF Inhibitors, 2021- 2031F |
6.5.3 India Autoimmune Disease Treatment Market Revenues & Volume, By IL Blockers, 2021- 2031F |
6.5.4 India Autoimmune Disease Treatment Market Revenues & Volume, By COX Inhibitors, 2021- 2031F |
6.5.5 India Autoimmune Disease Treatment Market Revenues & Volume, By Phosphodiesterase Type 4 Inhibitors, 2021- 2031F |
6.5.7 India Autoimmune Disease Treatment Market Revenues & Volume, By Diagnostic, 2021- 2031F |
6.5.8 India Autoimmune Disease Treatment Market Revenues & Volume, By Antinuclear Antibody Tests, 2021- 2031F |
6.5.9 India Autoimmune Disease Treatment Market Revenues & Volume, By Antinuclear Antibody Tests, 2021- 2031F |
6.6 India Autoimmune Disease Treatment Market, By Treatment |
6.6.1 Overview and Analysis |
6.6.2 India Autoimmune Disease Treatment Market Revenues & Volume, By Drugs, 2021- 2031F |
6.6.3 India Autoimmune Disease Treatment Market Revenues & Volume, By Physical Therapy, 2021- 2031F |
6.7 India Autoimmune Disease Treatment Market, By Product |
6.7.1 Overview and Analysis |
6.7.2 India Autoimmune Disease Treatment Market Revenues & Volume, By Diagnostic Equipment, 2021- 2031F |
6.7.3 India Autoimmune Disease Treatment Market Revenues & Volume, By Drugs, 2021- 2031F |
6.7.4 India Autoimmune Disease Treatment Market Revenues & Volume, By , 2021- 2031F |
7 India Autoimmune Disease Treatment Market Import-Export Trade Statistics |
7.1 India Autoimmune Disease Treatment Market Export to Major Countries |
7.2 India Autoimmune Disease Treatment Market Imports from Major Countries |
8 India Autoimmune Disease Treatment Market Key Performance Indicators |
8.1 Number of patients diagnosed with autoimmune diseases annually in India |
8.2 Adoption rate of innovative autoimmune disease treatments in urban centers |
8.3 Percentage of healthcare facilities offering specialized autoimmune disease treatment services |
8.4 Average waiting time for autoimmune disease treatment appointments |
8.5 Patient satisfaction rate with autoimmune disease treatment outcomes |
9 India Autoimmune Disease Treatment Market - Opportunity Assessment |
9.1 India Autoimmune Disease Treatment Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Autoimmune Disease Treatment Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 India Autoimmune Disease Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 India Autoimmune Disease Treatment Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.5 India Autoimmune Disease Treatment Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.6 India Autoimmune Disease Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.7 India Autoimmune Disease Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
10 India Autoimmune Disease Treatment Market - Competitive Landscape |
10.1 India Autoimmune Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 India Autoimmune Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here